| Literature DB >> 21104400 |
Tiny A de Boer1, Marijke C P Slieker-ten Hove, Curt W Burger, Mark E Vierhout.
Abstract
INTRODUCTION AND HYPOTHESIS: To study the prevalence and risk factors of overactive bladder (OAB) symptoms and its relationship with symptoms of pelvic organ prolapse (POP).Entities:
Mesh:
Year: 2010 PMID: 21104400 PMCID: PMC3072516 DOI: 10.1007/s00192-010-1323-x
Source DB: PubMed Journal: Int Urogynecol J ISSN: 0937-3462 Impact factor: 2.894
Fig. 1Flowchart of the study
Fig. 2Any OAB symptoms in relation to urgency, frequency and urge incontinence
Patients’ characteristics and details of previous pelvic operations
| Number of women | 1397 |
|---|---|
| Age (years)a | |
| 45–55 | 647 (46.9%) |
| 56–65 | 435 (31.5%) |
| 66–75 | 233 (16.9%) |
| 76–85 | 66 (4.8%) |
| Parity | |
| 0 | 120 (8.6%) |
| 1 | 215 (15.4%) |
| 2 | 675 (48.3%) |
| ≥3 | 387 (27.7%) |
| Body mass index (kg/m2)b | |
| <20 | 53 (3.9%) |
| 20–25 | 599 (43.9%) |
| 25–30 | 519 (38.0%) |
| ≥30 | 193 (14.1%) |
| Racec | |
| Caucasian | 1,351 (98.5%) |
| Non-Caucasian | 20 (1.5%) |
| Smoking | |
| Former smokingd | 326 (23.6%) |
| Current smokingd | 280 (20.3%) |
| Postmenopausal status | 1,009 (72.2%) |
| Hormone suppletione | 88 (6.4%) |
| Previous gynaecological surgery | |
| Prolapse surgeryh | 103 (7.4%) |
| Hysterectomyi | 234 (16.9%) |
| Incontinence surgeryj | 47 (3.4%) |
Data are presented as number of women (percentage)
aData on 16 women are missing
bData on 33 women are missing
cData on 26 women are missing
dData on 15 women are missing
eData on 30 women are missing
fData on 25 women are missing
gData on 18 women are missing
hData on 13 women are missing
iData on 14 women are missing
jData on 15 women are missing
Prevalence of overactive bladder symptoms and any OAB symptoms per age groupa
| Frequencyb | Urgencyc | Urge incontinenced | Any of the OAB symptoms | |
|---|---|---|---|---|
| 45–55 | 162 (25.3%) | 193 (30.9%) | 178 (27.7%) | 298 (46.1%) |
| 56–65 | 121 (28.4%) | 141 (33.7%) | 116 (26.9%) | 200 (46.2%) |
| 66–75 | 80 (35.9%) | 92 (40.5%) | 79 (35.0%) | 126 (54.5%) |
| 76–85 | 24 (37.5%) | 33 (54.1%) | 32 (48.5%) | 42 (63.6%) |
| Overall | 393 (28.7%) | 463 (34.4%) | 411 (29.8%) | 677 (48.6%) |
Data are presented as number of women (percentage)
aData on age category on 16 women are missing
bData on frequency on 28 women are missing
cData on urgency on 52 women are missing
dData on urge incontinence on 16 women are missing
Prevalence of prolapse symptomse in women with symptoms of OAB
| Prolapse symptoms | No prolapse symptoms |
| |
|---|---|---|---|
| Frequencyb | 66 (41.8%) | 320 (26.9%) | 0.000 |
| Urgencyc | 77 (49.7%) | 379 (32.4%) | 0.000 |
| Urge incontinenced | 64 (40.3%) | 340 (28.3%) | 0.003 |
| Any of the OAB symptomse | 84 (69.4%) | 588 (46.6%) | 0.000 |
Data are presented as number of women (percentage)
a P value using chi-square test to compare the difference between women with versus without prolapse symptoms.
bData on 28 women are missing
cData on 52 women are missing
dData on 16 women are missing
eData on four women are missing
fData on prolapse symptoms on 24 women are missing
Factors of the univariate logistic regression analysis on the various OAB symptoms
| Frequency OR (95% CI) | Urgency OR (95% CI) | Urge incontinence OR (95% CI) | Any OAB OR (95% CI) | ||
|---|---|---|---|---|---|
| Age (years)a | 45–55 | Ref | Ref | Ref | Ref |
| 56–65 | 1.2 (0.9, 1.5) | 1.1 (0.9, 1.5) | 1.0 (0.7,1.3) | 1.0 (0.8, 1.3) | |
| 66–75 |
|
|
|
| |
| 76–85 |
|
|
|
| |
| Parity | ≤2 | Ref | Ref | Ref | Ref |
| >2 | 1.3 (1.0, 1.7) | 1.0 (0.8, 1.3) | 1.0 (0.8, 1.3) | 1.2 (0.9, 1.5) | |
| Body mass index (kg/m2)b | <20 | 0.7 (0.3,1.5) |
| 0.7 (0.4, 1.5) | 0.6 (0.3, 1.0) |
| 20–25 | Ref | Ref | Ref | Ref | |
| 25–30 |
|
|
|
| |
| ≥30 |
|
|
|
| |
| Smoking | |||||
| Former smokingc | Yes |
| 1.2 (0.9, 1.6) | 1.0 (0.8, 1.4) | 1.1 (0.8, 1.4) |
| No | Ref | Ref | Ref | Ref | |
| Current smokingc | Yes | 1.0 (0.8,1.4) | 1.3 (1.0, 1.7) | 1.3 (1.0, 1.7) | 1.2 (1.0, 1.6) |
| No | Ref | Ref | Ref | Ref | |
| Postmenopausal status | Yes |
|
|
|
|
| No | Ref | Ref | Ref | Ref | |
| Hormonal suppletion therapye | Yes | 1.2 (0.7, 1.9) | 1.2 (0.7, 1.8) | 0.7 (0.4, 1.2) | 0.9 (0.6, 1.4) |
| No | Ref | Ref | Ref | Ref | |
| Previous gynaecological surgery | |||||
| Prolapse surgeryd | Yes |
|
|
|
|
| No | Ref | Ref | Ref | Ref | |
| Hysterectomyh | Yes |
| 1.3 (0.9, 1.7) | 1.3 (1.0, 1.8) | 1.3 (1.0, 1.7) |
| No | Ref | Ref | Ref | Ref | |
| Incontinence surgeryc | Yes |
|
|
|
|
| No | Ref | Ref | Ref | Ref | |
| Prolapse symptomsi | Yes |
|
|
|
|
| No | Ref | Ref | Ref | Ref | |
All values with P < 0.05 are illustrated in bold
Ref: reference
aData on 16 women are missing
bData on 33 women are missing
cData on 15 women are missing
dData on 13 women are missing
eData on 30 women are missing
fData on 25 women are missing
gData on 18 women are missing
hData on 14 women are missing
iData on 24 women are missing
Risk factors on OAB symptoms after multivariate regression analysis
| Frequency OR (95% CI) | Urgency OR (95% CI) | Urge incontinence OR (95% CI) | Any OAB OR (95% CI) | ||
|---|---|---|---|---|---|
| Age (years)a | 45–55 | Ref | Ref | Ref | |
| 56–65 | 1.0 (0.8, 1.4) | 0.9 (0.6, 1.1) | 0.9 (0.7, 1.2) | ||
| 66–75 | 1.4 (1.0, 2.0) | 1.3 (0.9, 1.8) | 1.3 (1.0, 1.8) | ||
| 76–85 | 2.7 (1.5, 4.9) | 2.2 (1.3, 3.8) | 2.1 (1.2, 3.7) | ||
| Body mass index (kg/m2)b | <20 | 0.7 (0.3, 1.6) | 0.4 (0.2, 0.9) | 0.7 (0.3, 1.5) | 0.5 (0.3, 1.0) |
| 20–25 | Ref | Ref | Ref | Ref | |
| 25–30 | 1.5 (1.1, 2.0) | 1.2 (0.9, 1.6) | 1.3 (1.0, 1.8) | 1.3 (1.0, 1.6) | |
| ≥30 | 1.7 (1.2, 2.4) | 2.2 (1.5, 3.1) | 2.0 (1.4, 2.9) | 2.2((1.5, 3.1) | |
| Smoking | |||||
| Smoking in the pastc | Yes | 1.4 (1.1, 1.9) | |||
| No | Ref | ||||
| Current smokingc | Yes | 1.7 (1.2, 2.3) | 1.4 (1.0, 1.8) | ||
| No | Ref | Ref | |||
| Postmenopausal status | Yes | 1.3 (1.0, 1.8) | |||
| No | Ref | ||||
| Previous gynaecological surgery | |||||
| Prolapse surgeryd | Yes | 2.3 (1.4, 3.6) | |||
| No | Ref | ||||
| Incontinence surgerye | Yes | 2.9 (1.5, 5.5) | 4.3 (2.3, 8.2) | 6.7 (2.8, 16.3) | |
| No | Ref | Ref | Ref | ||
| Prolapse symptomsf | Yes | 2.4 (1.6, 3.5) | 2.2 (1.4, 3.3) | 1.8 (1.2, 2.6) | 2.3 (1.5, 3.5) |
| No | Ref | Ref | Ref | Ref | |
| Variance explained by the modelg | 5.8% | 8.8% | 6.6% | 9.1% | |
OR odds rario, Ref reference
aData on 16 women are missing
bData on 33 women are missing
cData on 15 women are missing
dData on 13 women are missing
eData on 18 women are missing
fData on 24 women are missing
gNagelkerke R 2